X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (11384) 11384
Publication (1020) 1020
Book Review (844) 844
Book Chapter (17) 17
Conference Proceeding (16) 16
Magazine Article (9) 9
Dissertation (7) 7
Data Set (3) 3
Book / eBook (2) 2
Paper (2) 2
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (10586) 10586
humans (7655) 7655
quinazolines - pharmacology (7551) 7551
animals (5103) 5103
male (3150) 3150
female (3140) 3140
oncology (3025) 3025
cell line, tumor (2504) 2504
mice (2462) 2462
antineoplastic agents - pharmacology (2265) 2265
pharmacology & pharmacy (2203) 2203
quinazolines - therapeutic use (2154) 2154
receptor, epidermal growth factor - antagonists & inhibitors (1879) 1879
protein kinase inhibitors - pharmacology (1582) 1582
rats (1549) 1549
gefitinib (1480) 1480
cancer (1472) 1472
chemistry, medicinal (1436) 1436
quinazolines - chemistry (1414) 1414
receptor, epidermal growth factor - metabolism (1386) 1386
middle aged (1350) 1350
quinazolines - administration & dosage (1330) 1330
quinazolines - chemical synthesis (1290) 1290
lung neoplasms - drug therapy (1234) 1234
dose-response relationship, drug (1228) 1228
cell proliferation - drug effects (1211) 1211
adult (1140) 1140
erlotinib hydrochloride (1119) 1119
expression (1110) 1110
aged (1092) 1092
structure-activity relationship (1079) 1079
biochemistry & molecular biology (1013) 1013
antineoplastic agents - therapeutic use (1005) 1005
growth-factor receptor (990) 990
enzyme inhibitors - pharmacology (969) 969
carcinoma, non-small-cell lung - drug therapy (968) 968
phosphorylation (953) 953
receptor, epidermal growth factor - genetics (949) 949
apoptosis - drug effects (942) 942
signal transduction - drug effects (939) 939
egfr (936) 936
apoptosis (920) 920
mutation (871) 871
quinazolines (862) 862
tyrosine kinase inhibitor (834) 834
epidermal growth factor (819) 819
erlotinib (803) 803
chemotherapy (797) 797
quinazolines - adverse effects (757) 757
analysis (754) 754
cell biology (752) 752
signal transduction (743) 743
activation (698) 698
lung neoplasms - pathology (697) 697
research (682) 682
quinazolines - pharmacokinetics (668) 668
tyrphostins - pharmacology (663) 663
mice, nude (633) 633
xenograft model antitumor assays (625) 625
molecular structure (616) 616
article (613) 613
drug resistance, neoplasm (612) 612
therapy (611) 611
lung neoplasms - genetics (608) 608
cell lung-cancer (603) 603
cell survival - drug effects (586) 586
treatment outcome (573) 573
tumor cells, cultured (571) 571
protein kinase inhibitors - therapeutic use (564) 564
lung cancer (556) 556
cell line (555) 555
kinases (540) 540
drug synergism (539) 539
phosphorylation - drug effects (536) 536
time factors (533) 533
cells (532) 532
cells, cultured (530) 530
blotting, western (527) 527
antineoplastic combined chemotherapy protocols - therapeutic use (523) 523
tumors (519) 519
breast neoplasms - drug therapy (516) 516
tyrosine (516) 516
resistance (505) 505
care and treatment (500) 500
in-vitro (498) 498
carcinoma, non-small-cell lung - pathology (497) 497
breast cancer (487) 487
in vitro techniques (482) 482
chemistry, organic (469) 469
lung-cancer (466) 466
proteins (465) 465
quinazolines - metabolism (457) 457
receptor, erbb-2 - metabolism (447) 447
carcinoma, non-small-cell lung - genetics (446) 446
epidermal growth factor receptor (444) 444
neoplasms - drug therapy (441) 441
medicine & public health (439) 439
lung neoplasms - metabolism (438) 438
antineoplastic agents - chemistry (435) 435
mutations (435) 435
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (10880) 10880
Chinese (152) 152
German (126) 126
Japanese (118) 118
French (38) 38
Italian (23) 23
Spanish (23) 23
Russian (21) 21
Hungarian (15) 15
Polish (11) 11
Czech (4) 4
Ukrainian (3) 3
Bulgarian (2) 2
Danish (2) 2
Norwegian (2) 2
Croatian (1) 1
Hebrew (1) 1
Portuguese (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Psychopharmacology, ISSN 0033-3158, 12/2008, Volume 201, Issue 3, pp. 443 - 458
Fluoxetine has relatively high affinity for Gq/11 protein-coupled 5-HT2 receptors. Part of these receptors in brain are on astrocytes, where fluoxetine causes... 
Neurosciences | Biomedicine | Serotonin | Astrocytes | Fluoxetine | EGFR transactivation | fosB | c-fos | Pharmacology/Toxicology | Psychiatry | ERK | 5-HT 2B receptor | receptor | C-fos | FosB | 5-HT | SIGNALING PATHWAYS | PSYCHIATRY | TYROSINE KINASE | PHARMACOLOGICAL CHARACTERIZATION | CELL-PROLIFERATION | 5-HT2B receptor | NEUROSCIENCES | SEROTONIN REUPTAKE INHIBITORS | MESSENGER-RNA | TISSUE DISTRIBUTION | MECHANICAL-STRESS | CULTURED ASTROCYTES | PHARMACOLOGY & PHARMACY | R-FLUOXETINE | Receptor, Epidermal Growth Factor - genetics | Up-Regulation | Phosphorylation | Transcriptional Activation - genetics | Nitriles - pharmacology | Calcium - metabolism | Maleimides - pharmacology | Substrate Specificity | Extracellular Signal-Regulated MAP Kinases - metabolism | Quinazolines | Calcium - chemistry | Receptor, Serotonin, 5-HT2B - physiology | Dose-Response Relationship, Drug | Fluorobenzenes - pharmacology | Receptor, Epidermal Growth Factor - metabolism | Piperidines - pharmacology | Receptor, Serotonin, 5-HT2B - drug effects | Urea - analogs & derivatives | Egtazic Acid - analogs & derivatives | Indoles - pharmacology | Proto-Oncogene Proteins c-fos - antagonists & inhibitors | Astrocytes - drug effects | Fluoxetine - pharmacology | Butadienes - pharmacology | Gene Expression | Signal Transduction | Dipeptides - pharmacology | RNA, Messenger - genetics | Cells, Cultured | Proto-Oncogene Proteins c-fos - metabolism | Antidepressive Agents, Second-Generation - pharmacology | Protein Kinase C - antagonists & inhibitors | Tyrphostins - pharmacology | Chelating Agents - pharmacology | Antidepressive Agents, Second-Generation - antagonists & inhibitors | Fluoxetine - antagonists & inhibitors | Astrocytes - physiology | Animals | Egtazic Acid - pharmacology | Aminopyridines - pharmacology | Proto-Oncogene Proteins c-fos - genetics | Mice | Urea - pharmacology | Brain | Neurotransmitters | Antidepressants | Psychopharmacology | Cells | Index Medicus
Journal Article
Anti-Cancer Drugs, ISSN 0959-4973, 03/2013, Volume 24, Issue 3, pp. 251 - 259
Journal Article
Journal of Inorganic Biochemistry, ISSN 0162-0134, 12/2015, Volume 153, pp. 49 - 59
Heart tissue becomes zinc-depleted and the capacity to mobilize labile zinc is diminished, indicating zinc dyshomeostasis during ischemia/reperfusion (I/R).... 
Hypoxia | Reoxygenation | Proteolysis | Caspase-3 | Zinc | Apoptosis | ACTIVATION | RAT | MITOCHONDRIAL | BIOCHEMISTRY & MOLECULAR BIOLOGY | REPERFUSION INJURY | CARDIOMYOPATHY | CARDIAC-CELLS | DEATH | INTRACELLULAR ZINC | CHEMISTRY, INORGANIC & NUCLEAR | ACUTE MYOCARDIAL-INFARCTION | Receptor, Epidermal Growth Factor - genetics | Caspase Inhibitors - pharmacology | Phosphorylation | Receptor, ErbB-2 - genetics | Protein Multimerization | Caspase 3 - metabolism | Receptor, ErbB-2 - metabolism | RNA, Messenger - metabolism | Cell Hypoxia | Receptor, Epidermal Growth Factor - metabolism | Zinc Compounds - pharmacology | Amino Acid Chloromethyl Ketones - pharmacology | Receptor, ErbB-2 - antagonists & inhibitors | Proteasome Inhibitors - pharmacology | Benzothiazoles - pharmacology | Chlorides - pharmacology | Down-Regulation | RNA, Messenger - genetics | Rats | Tyrphostins - pharmacology | Cardiotonic Agents - pharmacology | Leupeptins - pharmacology | Myocytes, Cardiac - pathology | Animals | Myocytes, Cardiac - drug effects | Receptor, Epidermal Growth Factor - antagonists & inhibitors | Protein Kinase Inhibitors - pharmacology | Pyridines - pharmacology | Thiones - pharmacology | Quinazolines - pharmacology | Organometallic Compounds - pharmacology | Proteins | Membrane lipids | Inositol | RNA | Antifungal agents | Permeability | Antibacterial agents | Phosphotransferases | Tyrosine | Cell death | Index Medicus
Journal Article
British Journal of Pharmacology, ISSN 0007-1188, 10/2012, Volume 167, Issue 4, pp. 775 - 786
BACKGROUND AND PURPOSE Patients with chronic obstructive pulmonary disease (COPD) show a poor response to corticosteroids, which has been linked to oxidative... 
salmeterol | corticosteroid | severe asthma | PI3Kδ | formoterol | oxidative stress | COPD | CELLS | COMBINATION THERAPY | INHALED CORTICOSTEROIDS | AIRWAY INFLAMMATION | BUDESONIDE | ADRENERGIC AGONISTS | INTERLEUKIN-8 | ASTHMA CONTROL | OBSTRUCTIVE PULMONARY-DISEASE | PHARMACOLOGY & PHARMACY | PI3Kd | Ethanolamines - pharmacology | Asthma - metabolism | Formoterol Fumarate | Albuterol - pharmacology | Humans | Middle Aged | Oxidative Stress - physiology | Male | Fluticasone | Adrenergic beta-2 Receptor Agonists - pharmacology | 1-Phosphatidylinositol 4-Kinase - metabolism | Young Adult | Dexamethasone - pharmacology | U937 Cells | Adult | Female | Interleukin-8 - metabolism | Pulmonary Disease, Chronic Obstructive - metabolism | Chromones - pharmacology | Salmeterol Xinafoate | Adenine - analogs & derivatives | Leukocytes, Mononuclear - drug effects | Hydrogen Peroxide - pharmacology | Adrenal Cortex Hormones - pharmacology | Albuterol - analogs & derivatives | Morpholines - pharmacology | 1-Phosphatidylinositol 4-Kinase - antagonists & inhibitors | Adenine - pharmacology | Drug Resistance - drug effects | Receptors, Adrenergic, beta-2 - metabolism | Budesonide - pharmacology | Androstadienes - pharmacology | Aged | Quinazolines - pharmacology | Hydrogen peroxide | Dexamethasone | Asthma | Steroids | Oxidative stress | Chronic obstructive pulmonary disease | Index Medicus | Research Papers
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 10/2008, Volume 14, Issue 20, pp. 6456 - 6468
Purpose: It was the aim of our study to establish an extensive panel of non-small cell lung cancer (NSCLC) xenograft models useful for the testing of novel... 
xenograft | NSCLC | erlotinib | mutational analysis | anti-EGFR therapy | cetuximab | biomarker | TARGETED THERAPY | KRAS MUTATIONS | GROWTH-FACTOR RECEPTOR | NUDE-MICE | TUMOR XENOGRAFTS | GEFITINIB | ONCOLOGY | GENE-EXPRESSION | TYROSINE KINASE INHIBITOR | EGFR MUTATIONS | ANTITUMOR-ACTIVITY | Carcinoma, Large Cell - drug therapy | Lung Neoplasms - drug therapy | Receptor, Epidermal Growth Factor - genetics | Adenocarcinoma - pathology | Oligonucleotide Array Sequence Analysis | Carcinoma, Large Cell - pathology | Carcinoma, Squamous Cell - pathology | Humans | Lung Neoplasms - metabolism | Middle Aged | Drug Resistance, Neoplasm | Immunoblotting | Male | Gene Expression Profiling | Adenocarcinoma - metabolism | Biomarkers, Tumor - metabolism | Cetuximab | Disease Models, Animal | Genes, ras - genetics | Antibodies, Monoclonal - pharmacology | Carcinoma, Non-Small-Cell Lung - metabolism | Etoposide - pharmacology | Mutation - genetics | Adenocarcinoma - drug therapy | Small Cell Lung Carcinoma - pathology | Carcinoma, Squamous Cell - drug therapy | Mice, Nude | Mice, Inbred NOD | Biomarkers, Tumor - genetics | Mice | Carboplatin - pharmacology | Quinazolines - pharmacology | Deoxycytidine - analogs & derivatives | Erlotinib Hydrochloride | Paclitaxel - pharmacology | Prognosis | Carcinoma, Squamous Cell - metabolism | Deoxycytidine - pharmacology | Lung Neoplasms - pathology | Small Cell Lung Carcinoma - drug therapy | Tumor Suppressor Protein p53 - genetics | Small Cell Lung Carcinoma - metabolism | Antibodies, Monoclonal, Humanized | Receptor, Epidermal Growth Factor - metabolism | Vinblastine - analogs & derivatives | Polymerase Chain Reaction | Adult | Female | Antineoplastic Agents - pharmacology | Carcinoma, Non-Small-Cell Lung - pathology | Carcinoma, Large Cell - metabolism | Radiation-Sensitizing Agents - pharmacology | Tumor Suppressor Protein p53 - metabolism | Mice, SCID | Xenograft Model Antitumor Assays | Animals | Receptor, Epidermal Growth Factor - antagonists & inhibitors | Aged | Protein Kinase Inhibitors - pharmacology | Vinblastine - pharmacology | Carcinoma, Non-Small-Cell Lung - drug therapy | Antineoplastic Agents, Phytogenic - pharmacology | Index Medicus
Journal Article
Blood, ISSN 0006-4971, 2009, Volume 114, Issue 14, pp. 2984 - 2992
Journal Article
British Journal of Pharmacology, ISSN 0007-1188, 12/2014, Volume 171, Issue 24, pp. 5757 - 5773
Journal Article
Arteriosclerosis, Thrombosis, and Vascular Biology, ISSN 1079-5642, 09/2014, Volume 34, Issue 9, pp. 2078 - 2085
OBJECTIVE—In a phase III clinical trial (PLATelet inhibition and patient Outcomes, PLATO), ticagrelor provided better clinical outcomes than clopidogrel in... 
adenosine | aspirin | cyclooxygenase | platelet aggregation inhibitors | ISCHEMIA/REPERFUSION INJURY | ACUTE CORONARY SYNDROMES | PLATO | COMBINATION | ATORVASTATIN | ISCHEMIA-REPERFUSION INJURY | CLOPIDOGREL | PLATELET INHIBITION | PERIPHERAL VASCULAR DISEASE | CARDIOPROTECTION | HEMATOLOGY | Receptor, Adenosine A1 - physiology | Ticlopidine - therapeutic use | Nitric Oxide Synthase Type III - biosynthesis | Adenosine A1 Receptor Antagonists - pharmacology | Male | Receptor, Adenosine A2A - physiology | Cardiotonic Agents - therapeutic use | Cyclooxygenase 2 - biosynthesis | Myocardial Reperfusion Injury - pathology | Cyclooxygenase 2 - genetics | Adenosine - therapeutic use | Myocardial Infarction - pathology | Enzyme Induction - drug effects | Nitric Oxide Synthase Type III - physiology | Aspirin - pharmacology | Myocardial Reperfusion Injury - drug therapy | Drug Evaluation, Preclinical | Pyrazoles - pharmacology | Cyclooxygenase 2 Inhibitors - pharmacology | Rats | Cyclooxygenase 2 - physiology | Adenosine - pharmacology | Cardiotonic Agents - pharmacology | Nitric Oxide Synthase Type III - genetics | Rats, Sprague-Dawley | Ticlopidine - analogs & derivatives | Triazoles - pharmacology | Up-Regulation - drug effects | Adenosine A2 Receptor Antagonists - pharmacology | Animals | Myocardial Infarction - drug therapy | Adenosine - analogs & derivatives | Adenosine - physiology | 6-Ketoprostaglandin F1 alpha - metabolism | Quinazolines - pharmacology | Lipoxins - metabolism | Myocardial Reperfusion Injury - prevention & control | Index Medicus
Journal Article
Journal of Cardiovascular Pharmacology, ISSN 0160-2446, 09/2004, Volume 44, Issue 3, pp. 302 - 309
The mechanisms involved in the cardioprotector effect of red wine have not yet been completely elucidated but probably an endothelium-dependent vasodilator... 
Antihypertensive | EDHF | Brazilian red wine | Vasodilation | Endothelium | Flavonoids - antagonists & inhibitors | Male | Nitroglycerin - pharmacology | Yohimbine - pharmacology | Glyburide - pharmacology | Charybdotoxin - pharmacology | Oxadiazoles - pharmacology | Phenols - antagonists & inhibitors | Brazil | Polyphenols | Wine - adverse effects | Muscle, Smooth, Vascular - drug effects | Phenols - pharmacology | Administration, Oral | Rats | Atropine - pharmacology | Pressure | Vasoconstriction - drug effects | Indomethacin - pharmacology | Phenols - analysis | Pyrilamine - pharmacology | Perfusion | Vasodilation - drug effects | Quinazolines - pharmacology | Bradykinin - analogs & derivatives | Norepinephrine - pharmacology | Flavonoids - analysis | Rats, Wistar | Nitric Oxide Synthase - antagonists & inhibitors | Mesenteric Arteries - drug effects | Guanylate Cyclase - antagonists & inhibitors | Apamin - pharmacology | Endothelium, Vascular - physiology | Quinoxalines - pharmacology | Hypertension - chemically induced | Potassium Chloride - pharmacology | Hypertension - prevention & control | Clonidine - pharmacology | Blood Pressure - drug effects | Flavonoids - pharmacology | Vasodilation - physiology | Drug Therapy, Combination | Oxadiazoles - chemistry | Quinazolines - chemistry | Bradykinin - pharmacology | Acetylcholine - pharmacology | NG-Nitroarginine Methyl Ester - adverse effects | Alcohol Drinking - adverse effects | Clonidine - antagonists & inhibitors | Animals | Deoxycholic Acid - pharmacology | Acetylcholine - antagonists & inhibitors | Index Medicus
Journal Article
FASEB Journal, ISSN 0892-6638, 03/2017, Volume 31, Issue 3, pp. 1193 - 1203
VEGF inhibitors, including receptor tyrosine kinase inhibitors, are used as adjunct therapies in a number of cancer treatments. An emerging issue with these... 
Hypertension | Cancer therapy | Regional hemodynamics | RTKI | VEGF | SIGNALING PATHWAY INHIBITORS | BIOCHEMISTRY & MOLECULAR BIOLOGY | TOXICITY | CANCER | RENAL-CELL CARCINOMA | BLOOD-PRESSURE | CELL BIOLOGY | cancer therapy | GROWTH-FACTOR RECEPTOR | INDUCED HYPERTENSION | TARGETED THERAPIES | regional hemodynamics | BIOLOGY | SUNITINIB | hypertension | FACTOR VEGF RECEPTORS | Niacinamide - analogs & derivatives | Male | Angiotensin II Type 1 Receptor Blockers - pharmacology | Adrenergic beta-Antagonists - pharmacology | Propranolol - pharmacology | Regional Blood Flow - drug effects | Piperidines - pharmacology | Propranolol - administration & dosage | Receptor Protein-Tyrosine Kinases - antagonists & inhibitors | Quinazolines - administration & dosage | Adrenergic beta-Antagonists - administration & dosage | Angiotensin II Type 1 Receptor Blockers - administration & dosage | Piperidines - administration & dosage | Consciousness | Pyrimidines - administration & dosage | Losartan - pharmacology | Rats | Pyrimidines - pharmacology | Sulfonamides - pharmacology | Rats, Sprague-Dawley | Niacinamide - administration & dosage | Protein Kinase Inhibitors - administration & dosage | Animals | Phenylurea Compounds - administration & dosage | Hemodynamics - drug effects | Phenylurea Compounds - pharmacology | Protein Kinase Inhibitors - pharmacology | Losartan - administration & dosage | Niacinamide - pharmacology | Quinazolines - pharmacology | Sulfonamides - administration & dosage | Drugs | Physiological effects | Drug development | Arteries | Rodents | Aorta | Protein-tyrosine kinase receptors | Blood pressure | Propranolol | Vascular endothelial growth factor | Protein-tyrosine kinase | Tyrosine | Jugular vein | Kidneys | Regional analysis | Catheters | Inhibitors | Coronary vessels | Phentolamine | Hemodynamics | Circulatory system | Cancer | Peritoneum | Index Medicus | Research
Journal Article
The Journal of Clinical Endocrinology & Metabolism, ISSN 0021-972X, 07/2013, Volume 98, Issue 7, pp. E1163 - E1172
Context: Inhibition of dipeptidyl peptidase-4 (DPP-4) is a potent strategy to increase glucose-dependent insulinotropic polypeptide and glucagon like peptide 1... 
APOPTOSIS | HUMAN PANCREATIC-ISLETS | METABOLIC SYNDROME | HYPERGLYCEMIA | ALPHA-CELLS | GLUCOSE | ENDOCRINOLOGY & METABOLISM | RECEPTOR EXPRESSION | RANDOMIZED CONTROLLED-TRIAL | BI 1356 | DIPEPTIDYL PEPTIDASE-IV | Palmitic Acid - metabolism | Dipeptidyl Peptidase 4 - metabolism | Antioxidants - chemistry | Dipeptidyl Peptidase 4 - chemistry | Humans | Interleukin 1 Receptor Antagonist Protein - genetics | Peptide Fragments - pharmacology | Interleukin-1beta - genetics | Dipeptidyl-Peptidase IV Inhibitors - pharmacology | Anti-Inflammatory Agents, Non-Steroidal - pharmacology | Insulin-Secreting Cells - metabolism | Anti-Inflammatory Agents, Non-Steroidal - antagonists & inhibitors | Glucagon-Like Peptide 1 - agonists | Interleukin-1beta - metabolism | Interleukin 1 Receptor Antagonist Protein - metabolism | Purines - antagonists & inhibitors | Linagliptin | Interleukin 1 Receptor Antagonist Protein - pharmacology | Sitagliptin Phosphate | Insulin Secretion | Interleukin-1beta - antagonists & inhibitors | Recombinant Proteins - metabolism | Cell Survival - drug effects | Recombinant Proteins - antagonists & inhibitors | Cytokines - metabolism | Glucagon-Like Peptide 1 - metabolism | Purines - pharmacology | Tissue Culture Techniques | Dipeptidyl-Peptidase IV Inhibitors - chemistry | Glucagon-Like Peptide 1 - chemistry | Antioxidants - pharmacology | Recombinant Proteins - pharmacology | Insulin-Secreting Cells - immunology | Triazoles - pharmacology | Insulin - metabolism | Insulin-Secreting Cells - drug effects | Drug Inverse Agonism | Protein Stability - drug effects | Pyrazines - pharmacology | Quinazolines - pharmacology | Quinazolines - antagonists & inhibitors | Index Medicus | Abridged Index Medicus
Journal Article
Immunology, ISSN 0019-2805, 07/2010, Volume 130, Issue 3, pp. 399 - 409
Calcitonin gene‐related peptide (CGRP) is widely distributed and plays important roles in a wide array of biological functions. It is enriched in primary... 
cytokine | macrophage | chemokine | enzyme‐linked immunosorbent assay | neuropeptide | Chemokine | Neuropeptide | Enzyme-linked immunosorbent assay | Cytokine | Macrophage | TRIGEMINAL GANGLION | ALVEOLAR EPITHELIAL-CELLS | NECROSIS-FACTOR-ALPHA | ADRENOMEDULLIN RECEPTORS | IMMUNOLOGY | RAT SENSORY NEURONS | HUMAN MONOCYTES | CYTOKINE PRODUCTION | enzyme-linked immunosorbent assay | RECEPTOR-LIKE RECEPTOR | NF-KAPPA-B | ACTIVITY-MODIFYING PROTEIN-1 | Interleukin-6 - antagonists & inhibitors | Nitriles - pharmacology | Receptor, trkA - antagonists & inhibitors | Receptor, trkA - immunology | Intracellular Signaling Peptides and Proteins - immunology | Peptide Fragments - pharmacology | Calcitonin Receptor-Like Protein | Nitrobenzenes - pharmacology | Sulfones - pharmacology | Nerve Growth Factor - antagonists & inhibitors | I-kappa B Proteins - antagonists & inhibitors | Receptors, Calcitonin - antagonists & inhibitors | Antibodies - immunology | Toll-Like Receptor 4 - agonists | Calcitonin Gene-Related Peptide - metabolism | Interleukin-1beta - antagonists & inhibitors | Cell Line | Dinoprostone - pharmacology | Cyclooxygenase 2 Inhibitors - pharmacology | Cytokines - metabolism | Calcitonin Gene-Related Peptide - pharmacology | Intracellular Signaling Peptides and Proteins - antagonists & inhibitors | Enzyme Inhibitors - pharmacology | Interleukin-1beta - immunology | Membrane Proteins - immunology | Sulfonamides - pharmacology | Piperazines - pharmacology | Cycloheximide - pharmacology | Antibodies - pharmacology | Macrophages - metabolism | Animals | Receptors, Calcitonin - immunology | Membrane Proteins - antagonists & inhibitors | Interleukin-6 - immunology | Lipopolysaccharides - pharmacology | Macrophages - drug effects | Receptor Activity-Modifying Proteins | Chemokines - metabolism | Mice | Kinetics | Quinazolines - pharmacology | Dactinomycin - pharmacology | Peptides | Immunotherapy | Prostaglandins E | Nerve growth factor | Inflammation | Macrophages | Mitogens | Cytokines | Rodents | Immune system | Index Medicus | Original
Journal Article